Nitrosamine Concerns Spur Precautionary Testing Of Rifampicin In EU
Probe Into Presence Of Nitrosamine Impurity In Rifampicin Medicines Is Ongoing
Executive Summary
National regulators throughout the EU will ask manufacturers of rifampicin-containing medicines to check their products for nitrosamine impurities before they are released for sale.